SYRE holders · CITADEL ADVISORS LLC 13F · SYRE stock
CITADEL ADVISORS LLC Spyre Therapeutics Inc. (SYRE) 13F holding
CITADEL ADVISORS LLC reported 108,135 SYRE shares valued at $5.5M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest SYRE 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the SYRE holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 108,135 | $5.5M | COM NEW |
| 2025-12-31 | 63,904 | $2.1M | COM NEW |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.